|
2024
|
Invention
|
Formulations.
There is provided an alkali metal salt of 4-chloro-N-[2-[(4-chlorophenyl)methyl]-3... |
|
|
Invention
|
Treatment of cancer with the pdk inhibitor 4-chloro-n-(2-(4-chlorobenzyl)-3-oxo-2,3-dihydro-1,2,4... |
|
|
Invention
|
Methods for regulating blood glucose levels using a dual ampk activator and mitochondrial uncoupl... |
|
|
Invention
|
Methods of treating cardiomyopathy induced by metabolic inflexibility. Provided herein are method... |
|
2023
|
Invention
|
Formulations. There is provided an alkali metal salt of 4-chloro-N-[2-[(4-chlorophenyl)methyl]-3-... |
|
2022
|
Invention
|
Thiadiazolone derivatives useful as ampk activator.
The invention relates to a compound of formu... |
|
|
Invention
|
Thiadiazolone derivatives useful as ampk activator. The invention relates to a compound of formul... |
|
|
Invention
|
4-chloro-n-[2-[(4-chlorophenyl)methyl]-3-oxo-1,2,4-thiadiazol-5-yl]benzamide for use in medicine.... |
|
2021
|
Invention
|
Thiadiazolone derivatives and their use as ampk agonists for the treatment of diabetes and relate... |
|
2020
|
Invention
|
New formulations. There is provided an alkali metal salt of 4-chloro-N-[2-[(4-chlorophenyl)methyl... |
|
2018
|
Invention
|
Methods of treating diabetes in severe insulin-resistant diabetic subjects.
This invention relat... |
|
|
Invention
|
Methods of treating diabetes in severe insulin-resistant diabetic subjects. This invention relate... |
|
2010
|
Invention
|
Compounds useful as inhibitors as ampk. According to the invention there is provided a compound o... |
|
2009
|
Invention
|
Heterocyclic compounds and their use as ampk activators. There is provided a compound of formula ... |
|
2008
|
Invention
|
Dithiazolidine and thiazolidine derivatives as anticancer agents. There is provided a compound of... |
|
|
Invention
|
Compounds useful as medicaments. There is provided the following compound of formula (I): which c... |
|
|
Invention
|
Thiazolidinone derivatives useful in the treatment of cancer and disorders caused by excess adipo... |
|
|
Invention
|
New combination for use in the treatment of cancer. There is provided combination products compri... |
|
2007
|
Invention
|
Combination for use in the treatment of cancer, comprising tamoxifen or an aromatase inhibitor. T... |
|
|
Invention
|
Medical use of bmp-2 and/ or bmp-4. The present invention provides the use of a bone morphogeneti... |
|
2006
|
Invention
|
Use of thiazole derivatives and analogues in the treatment of cancer.
There is provided a use... |
|
|
Invention
|
Use of thiazole derivatives and analogues in disorders caused by free fatty acids.
There is prov... |
|
|
Invention
|
Use of thiazole derivatives and analogues in the treatment of cancer. There is provided a use of ... |
|
|
Invention
|
Use of thiazole derivatives and analogues in disorders caused by free fatty acids. There is provi... |
|
|
Invention
|
Use of thiazole derivatives and analogues in disorders caused by free fatty acids.
The... |
|
|
Invention
|
Use of thiazole derivatives and analogues in the treatment of cancer.
There is provide... |
|
2005
|
Invention
|
Retinoic acid stimulates differentiation of pancreatic progenitor cells into insulin producing ce... |
|
|
Invention
|
A method for differentiation of pancreatic stem cells into insulin producing cells. The invention... |
|
|
Invention
|
Nucleotide derivatives for the treatment of type 2 diabetes and other disorders. The present inve... |
|
2004
|
Invention
|
New diabetes type 2 animal model. A diabetes type 2 model laboratory animal is disclosed which co... |
|
|
Invention
|
New diabetes type 2 animal model.
A diabetes type 2 model laboratory animal is disclos... |
|
2003
|
Invention
|
Targets for type i and type ii diabetes. The present ivnention relates to assay systems and metho... |
|
2002
|
Invention
|
Animal and cell models for type ii diabetes and their use. A transgenic diabetes type II model la... |
|
2001
|
Invention
|
Animal and cell models for type ii diabetes and their use.
A transgenic diabetes type ... |
